Skip to main content
. 2023 Jul 29;13(15):2208. doi: 10.3390/nano13152208

Figure 3.

Figure 3

In vivo coronal CT images after intravenous injection of (A) the commercial iodine contrast agent Iopamidol®-370 (150 µL; 175 mg I/mL) and (B) CeO2NPs-MSA solution (200 μL, 10 mg Ce/mL) at various representative times, from 2 min post-injection up to 24 h.